Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • neetu
    Member
    • Oct 2011
    • 12

    #1

    MACS version 1.3.0 versus MACS version 1.4.0

    i have tried calling peaks by both the versions of MACS. incidentally i got a model with 1.3.7 but did not get any model with 1.4.0 a warning instead
    (too few paired peaks (0) so I can not build the model! Broader your MFOLD range parameter may erase this error. If it still can't build the model, please use --nomodel and --shiftsize 100 instead.)

    the output for peak calling is also different with the two versions. Now my question is: Is it better to continue using the older version? does anybody knows the advantages of the newer version as compared to the older version? galaxy still uses version 1.3.7. what is the most commonly preferred version?

    Thanks in advance
    Neetu
  • ffinkernagel
    Senior Member
    • Oct 2009
    • 110

    #2
    Macs 1.4.0 (note that 1.4.1 is the current version) has a number of changes and bugfixes. See http://liulab.dfci.harvard.edu/MACS/ChangeLog.html for the list.

    Among them the handling of duplicate reads, changes in how samples are scaled etc, all could affect the output.

    Personally, I'd go with the newer version. Adjust your mfold (the old one had x >= 32, the new one 10 <= x <= 30), and you should get comparable results for strong peaks.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-13-2026, 12:22 PM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-11-2026, 10:35 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    33 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    51 views
    0 reactions
    Last Post SEQadmin2  
    Working...